Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  472 نتائج ل ""Hypolipidemic Agents""

فلترة النتائج

Subject : atherosclerosis
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review.

  • Authors : Deerochanawong C; Diabetes and Endocrinology Unit, Department of Medicine, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.; Kim SG

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Diabetes & metabolism journal [Diabetes Metab J] 2024 Mar; Vol. 48 (2), pp. 184-195. Date of Electronic Publication: 2024 Jan 26.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Oxidized dietary lipids induce vascular inflammation and atherogenesis in post-menopausal rats: estradiol and selected antihyperlipidemic drugs restore vascular health in vivo.

  • Authors : Folahan JT; School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71209, USA.; Department of Pharmacology and Therapeutics, Faculty of Basic Clinical Sciences, University of Ilorin, Ilorin, Kwara-State, Nigeria.

Subjects: Estradiol*/Estradiol*/Estradiol*/pharmacology ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy; Rats

  • Source: Lipids in health and disease [Lipids Health Dis] 2023 Jul 26; Vol. 22 (1), pp. 107. Date of Electronic Publication: 2023 Jul 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-511X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Clearing the Clutter: Antiatherosclerotic activity of Eucalyptus camaldulensis crude extract.

  • Authors : -Ain QU; Department of Physiology, University of Karachi, Karachi, Pakistan.; Ahmed A

Subjects: Eucalyptus*/Eucalyptus*/Eucalyptus*/chemistry; Aortic Diseases/Aortic Diseases/Aortic Diseases/*prevention & control ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*prevention & control

  • Source: Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2021 Nov; Vol. 34 (6), pp. 2205-2211.Publisher: Faculty of Pharmacy, University of Karachi Country of Publication: Pakistan NLM ID: 9426356 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Hypocholesterolaemic and Anti-Atherogenic Effects of Palm-Based Oils (NoveLin I and NoveLin II) in Cholesterol-Fed Rabbits.

  • Authors : Che Idris CA; Malaysian Palm Oil Board, No. 6, Persiaran Institusi, Bandar Baru Bangi, Kajang 43000, Selangor, Malaysia.; Wai Lin S

Subjects: Atherosclerosis/Atherosclerosis/Atherosclerosis/*etiology ; Dietary Fats/Dietary Fats/Dietary Fats/*administration & dosage ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*chemistry

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2020 May 06; Vol. 17 (9). Date of Electronic Publication: 2020 May 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Statins in Children, an Update.

  • Authors : Fiorentino R; Department of Paediatrics, University of Chieti, Via dei Vestini, 66100 Chieti, Italy.; Chiarelli F

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects ; Dyslipidemias*/Dyslipidemias*/Dyslipidemias*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jan 10; Vol. 24 (2). Date of Electronic Publication: 2023 Jan 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cardiac Alarmins as Residual Risk Markers of Atherosclerosis under Hypolipidemic Therapy.

  • Authors : Suica VI; Institute of Cellular Biology and Pathology 'Nicolae Simionescu', 050568 Bucharest, Romania.; Uyy E

Subjects: Annexin A1* ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/metabolism ; HMGB1 Protein*/HMGB1 Protein*/HMGB1 Protein*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2022 Sep 22; Vol. 23 (19). Date of Electronic Publication: 2022 Sep 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Mitochondrial Genetic Background May Impact Statins Side Effects and Atherosclerosis Development in Familial Hypercholesterolemia.

  • Authors : Ruiz-Pesini E; Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50009 Zaragoza, Spain.; Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, 50013 Zaragoza, Spain.

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects ; Hyperlipoproteinemia Type II*/Hyperlipoproteinemia Type II*/Hyperlipoproteinemia Type II*/complications ; Hyperlipoproteinemia Type II*/Hyperlipoproteinemia Type II*/Hyperlipoproteinemia Type II*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2022 Dec 28; Vol. 24 (1). Date of Electronic Publication: 2022 Dec 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022).

  • Authors : Banach M; Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Rzgowska 281/289, 93-338, Lodz, Poland. .; Department of Cardiology and Congenital Heart Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. .

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Nov 28; Vol. 21 (1), pp. 263. Date of Electronic Publication: 2022 Nov 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins.

  • Authors : Kim K; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications

  • Source: Diabetes & metabolism journal [Diabetes Metab J] 2022 Jul; Vol. 46 (4), pp. 517-532. Date of Electronic Publication: 2022 Jul 27.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Design of Multifaceted Antioxidants: Shifting towards Anti-Inflammatory and Antihyperlipidemic Activity.

  • Authors : Tzara A; Division of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National & Kapodistrian University of Athens, 15771 Athens, Greece.; Lambrinidis G

Subjects: Antioxidants/Antioxidants/Antioxidants/*chemistry ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*drug therapy ; Hyperlipidemias/Hyperlipidemias/Hyperlipidemias/*drug therapy

  • Source: Molecules (Basel, Switzerland) [Molecules] 2021 Aug 14; Vol. 26 (16). Date of Electronic Publication: 2021 Aug 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  472 نتائج ل ""Hypolipidemic Agents""